• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亨廷顿舞蹈病纹状体氢质子磁共振波谱变化的临床相关性

Clinical correlation of striatal 1H MRS changes in Huntington's disease.

作者信息

Sánchez-Pernaute R, García-Segura J M, del Barrio Alba A, Viaño J, de Yébenes J G

机构信息

Department of Neurology, Fundación Jiménez Díaz, Universidad Autónoma, Madrid, Spain.

出版信息

Neurology. 1999 Sep 11;53(4):806-12. doi: 10.1212/wnl.53.4.806.

DOI:10.1212/wnl.53.4.806
PMID:10489045
Abstract

OBJECTIVE

To study the clinical significance of metabolic alterations as measured in vivo with proton MRS in the striatum of patients with Huntington's disease (HD).

METHODS

Localized, single-voxel MRS was performed on the basal ganglia of 10 HD patients (4 presymptomatic gene carriers and 6 akinetic patients) and 5 age-matched healthy individuals. Metabolite quantification was performed by referring the areas of the respective spectral peaks to that of water in the analyzed voxel. The spectroscopic findings were correlated with motor and cognitive performance in several specific tests and with the length of the CAG repeat expansion normalized for age.

RESULTS

N-acetylaspartate (NAA) and creatine were reduced markedly in both groups of patients, particularly in the advanced group (approximately 60%), but the decrease was also significant in presymptomatic patients (approximately 30%) whose motor and cognitive performances were within the normal range. Both metabolites correlated highly with the motor score of the Unified Huntington's Disease Rating Scale and with computed measurements of saccadic and tapping speed. Creatine reduction was also well correlated with performance in cognitive timed tasks and with the length of CAG expansion (r = -0.81).

CONCLUSION

The creatine signal appears to be an interesting marker for progression in HD and could be useful in assessing therapeutic outcome, particularly during the initial stages when most clinical indices are still within the normal range.

摘要

目的

研究采用质子磁共振波谱(MRS)在体测量亨廷顿舞蹈病(HD)患者纹状体代谢改变的临床意义。

方法

对10例HD患者(4例症状前基因携带者和6例运动不能患者)及5名年龄匹配的健康个体的基底神经节进行定位单体素MRS检查。通过将各光谱峰面积与分析体素内水的面积进行参照来进行代谢物定量分析。将光谱学结果与多项特定测试中的运动和认知表现以及根据年龄标准化的CAG重复扩增长度进行关联分析。

结果

两组患者的N-乙酰天门冬氨酸(NAA)和肌酸均显著降低,尤其是晚期组(约60%),但在症状前患者中降低也很显著(约30%),而这些患者的运动和认知表现均在正常范围内。这两种代谢物均与统一亨廷顿舞蹈病评定量表的运动评分以及扫视和敲击速度的计算测量值高度相关。肌酸降低也与认知定时任务的表现以及CAG扩增长度密切相关(r = -0.81)。

结论

肌酸信号似乎是HD病情进展的一个有趣标志物,可能有助于评估治疗效果,尤其是在大多数临床指标仍在正常范围内的初始阶段。

相似文献

1
Clinical correlation of striatal 1H MRS changes in Huntington's disease.亨廷顿舞蹈病纹状体氢质子磁共振波谱变化的临床相关性
Neurology. 1999 Sep 11;53(4):806-12. doi: 10.1212/wnl.53.4.806.
2
Heterogeneity in 1H-MRS profiles of presymptomatic and early manifest Huntington's disease.症状前和早期显性亨廷顿舞蹈病的1H-MRS谱的异质性。
Brain Res. 2005 Jan 7;1031(1):82-9. doi: 10.1016/j.brainres.2004.10.030.
3
Brain metabolite alterations and cognitive dysfunction in early Huntington's disease.早期亨廷顿病的脑代谢物改变与认知功能障碍。
Mov Disord. 2012 Jun;27(7):895-902. doi: 10.1002/mds.25010. Epub 2012 May 30.
4
1H NMR spectroscopy studies of Huntington's disease: correlations with CAG repeat numbers.亨廷顿舞蹈症的核磁共振氢谱研究:与CAG重复序列数的相关性
Neurology. 1998 May;50(5):1357-65. doi: 10.1212/wnl.50.5.1357.
5
In vivo imaging of brain glutamate defects in a knock-in mouse model of Huntington's disease.亨廷顿舞蹈病基因敲入小鼠模型中脑谷氨酸缺陷的体内成像
Neuroimage. 2016 Oct 1;139:53-64. doi: 10.1016/j.neuroimage.2016.06.023. Epub 2016 Jun 16.
6
Bradykinesia in early Huntington's disease.早期亨廷顿舞蹈病中的运动迟缓
Neurology. 2000 Jan 11;54(1):119-25. doi: 10.1212/wnl.54.1.119.
7
Increased brain tissue sodium concentration in Huntington's Disease - a sodium imaging study at 4 T.亨廷顿病患者脑组织钠离子浓度增加——4T 下的钠成像研究。
Neuroimage. 2012 Oct 15;63(1):517-24. doi: 10.1016/j.neuroimage.2012.07.009. Epub 2012 Jul 14.
8
Neurochemical changes in the progression of Huntington's disease: A meta-analysis of in vivoH-MRS studies.亨廷顿病进展过程中的神经化学变化:体内 H-MRS 研究的荟萃分析。
Neurobiol Dis. 2024 Sep;199:106574. doi: 10.1016/j.nbd.2024.106574. Epub 2024 Jun 22.
9
1H magnetic resonance spectroscopy in preclinical Huntington disease.临床前亨廷顿病的氢质子磁共振波谱分析
Brain Res. 2007 Sep 7;1168:67-71. doi: 10.1016/j.brainres.2007.05.082. Epub 2007 Jul 17.
10
A longitudinal study of magnetic resonance spectroscopy Huntington's disease biomarkers.一项关于磁共振波谱亨廷顿舞蹈病生物标志物的纵向研究。
Mov Disord. 2015 Mar;30(3):393-401. doi: 10.1002/mds.26118. Epub 2015 Feb 18.

引用本文的文献

1
Breaking Barriers in Huntington's Disease Therapy: Focused Ultrasound for Targeted Drug Delivery.突破亨廷顿病治疗的障碍:聚焦超声用于靶向给药。
Neurochem Res. 2025 Jan 3;50(1):68. doi: 10.1007/s11064-024-04302-w.
2
Early Diagnosis of Huntington Disease: Insights from Magnetic Resonance Spectroscopy-A Systematic Review.亨廷顿病的早期诊断:磁共振波谱学的见解——一项系统综述
J Clin Med. 2024 Oct 25;13(21):6390. doi: 10.3390/jcm13216390.
3
Neuroimaging to Facilitate Clinical Trials in Huntington's Disease: Current Opinion from the EHDN Imaging Working Group.
神经影像学在亨廷顿病临床试验中的应用:EHDN 影像学工作组的最新观点。
J Huntingtons Dis. 2024;13(2):163-199. doi: 10.3233/JHD-240016.
4
Longitudinal evaluation of proton magnetic resonance spectroscopy metabolites as biomarkers in Huntington's disease.将质子磁共振波谱代谢物作为亨廷顿舞蹈病生物标志物的纵向评估
Brain Commun. 2022 Oct 12;4(6):fcac258. doi: 10.1093/braincomms/fcac258. eCollection 2022.
5
Neurochemical correlates of synapse density in a Huntington's disease mouse model.亨廷顿病小鼠模型中突触密度的神经化学相关性。
J Neurochem. 2023 Jan;164(2):226-241. doi: 10.1111/jnc.15714. Epub 2022 Nov 11.
6
Non-invasive assessment of disease progression and neuroprotective effects of dietary coconut oil supplementation in the ALS SOD1 mouse model: A H-magnetic resonance spectroscopic study.非侵入性评估疾病进展和饮食椰子油补充对 ALS SOD1 小鼠模型的神经保护作用:一项 H 磁共振波谱研究。
Neuroimage Clin. 2018;20:1092-1105. doi: 10.1016/j.nicl.2018.09.011. Epub 2018 Sep 19.
7
Expanded neurochemical profile in the early stage of Huntington disease using proton magnetic resonance spectroscopy.使用质子磁共振波谱法对亨廷顿病早期神经化学特征的扩展研究
NMR Biomed. 2018 Mar;31(3). doi: 10.1002/nbm.3880. Epub 2018 Jan 9.
8
Rating scales for cognition in Huntington's disease: Critique and recommendations.亨廷顿病认知评定量表:评价与建议。
Mov Disord. 2018 Feb;33(2):187-195. doi: 10.1002/mds.27227. Epub 2017 Dec 26.
9
Comparison of spinocerebellar ataxia type 3 mouse models identifies early gain-of-function, cell-autonomous transcriptional changes in oligodendrocytes.3型脊髓小脑共济失调小鼠模型的比较确定了少突胶质细胞早期功能获得性、细胞自主转录变化。
Hum Mol Genet. 2017 Sep 1;26(17):3362-3374. doi: 10.1093/hmg/ddx224.
10
Characterization of Behavioral, Neuropathological, Brain Metabolic and Key Molecular Changes in zQ175 Knock-In Mouse Model of Huntington's Disease.亨廷顿舞蹈病zQ175基因敲入小鼠模型的行为、神经病理学、脑代谢及关键分子变化特征
PLoS One. 2016 Feb 9;11(2):e0148839. doi: 10.1371/journal.pone.0148839. eCollection 2016.